Author

Amany M Kamal

Lecturer of Biochemistry, Faculty of Pharmacy, Ain Shams University - Cited by 97 - biochemistry - molecular biology - nutrition

Biography

Dr. Amany M Kamal is a versatile writer and scientist that published extensively in Microbiology. He is affiliated with the Department of Parasitology, Faculty of Medicine, Minia University, Minia, Egypt.  
Title
Cited by
Year
Expression of inhibitor of apoptosis protein (IAP) livin/BIRC7 in acute leukemia in adults: correlation with prognostic factors and outcome
HO El-Mesallamy, HM Hegab, AM KamalLeukemia research 35 (12), 1616-1622, 2011201
34
2011
Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes
AM Kamal, EF Wasfey, WR Elghamry, OM Sabry, HA Elghobary, ...Clinical Biochemistry 96, 13-18, 2021202
19
2021
Expression of thioredoxin-1 (TXN) and its relation with oxidative DNA damage and treatment outcome in adult AML and ALL: A comparative study
AM Kamal, NM Hamdy, HM Hegab, HO El-MesallamyHematology 21 (10), 567-575, 2016201
17
2016
The immune checkpoints Cytotoxic T lymphocyte antigen‐4 and Lymphocyte activation gene‐3 expression is up‐regulated in acute myeloid leukemia
SM Radwan, NS Elleboudy, NA Nabih, AM KamalHla 96 (1), 3-12, 2020202
13
2020
Expression of immune check point gene TIM‑3 in patients newly diagnosed with acute myeloid leukemia: Significance and impact on outcome
AM Kamal, NA Nabih, NS Elleboudy, SM RadwanOncology Letters 21 (4), 1-9, 2021202
8
2021
The prospective prognostic value of the immune checkpoint BTLA expression in adult acute myeloid leukemia patients
SM Radwan, NS Elleboudy, NA Nabih, A El-kholy, AM KamalEgyptian journal of medical human genetics 22, 1-8, 2021202
3
2021
Mixed Lineage Kinase Domain-Like Pseudokinase (MLKL) Gene Expression in Human Atherosclerosis with and without Type 2 Diabetes Mellitus
AM Kamal, SA Sebak, EF SanadIranian Biomedical Journal 25 (4), 265, 20220
1
2021
AML-273: The Immune Checkpoints CTLA-4 and LAG-3 Expression is Up-Regulated in Acute Myeloid Leukemia
S Radwan, N Elleboudy, N Nabih, A KamalClinical Lymphoma Myeloma and Leukemia 20, S98, 2020202
1
2020
AML-272: The Immune Checkpoint BTLA Expression: A Potential Prognostic Biomarker for Acute Myeloid Leukemia Patients
S Radwan, N Elleboudy, N Nabih, A El-kholy, A KamalClinical Lymphoma Myeloma and Leukemia 20, S98, 2020202
1
2020

Referred From: https://scholar.google.com.eg/citations?user=uBjDKtYAAAAJ&hl=en

Cited by
Citations 97
h-index 5
i10-index 4
Recommended Journals
Open Access Journals